The pharma company have entered into a licensing agreement with PanTheryx, Inc. that grants the exclusive right to market and distribute PanTheryx’s nutritional intervention, DiaResQ, for infectious diarrhoea in India and Nepal.
| Subscribe To Our Free Newsletter |
